Literature DB >> 8620447

Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro.

J Escribano1, G L Alonso, M Coca-Prados, J A Fernandez.   

Abstract

Extracts of saffron (Crocus sativus L.) have been reported to inhibit cell growth of human tumor cells. In order to study the cytotoxic effect of the characteristic compounds of saffron spice, we have isolated crocin, crocetin, picrocrocin and safranal. Doses inducing 50% cell growth inhibition (LD50) on HeLa cells were 2.3 mg/ml for an ethanolic extract of saffron dry stigmas, 3 mM for crocin, 0.8 mM for safranal and 3 mM for picrocrocin. Crocetin did not show cytotoxic effect. Cells treated with crocin exhibited wide cytoplasmic vacuole-like areas, reduced cytoplasm, cell shrinkage and pyknotic nuclei, suggesting apoptosis induction. Considering its water-solubility and high inhibitory growth effect, crocin is the more promising saffron compound to be assayed as a cancer therapeutic agent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620447     DOI: 10.1016/0304-3835(95)04067-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  57 in total

1.  Anti-inflammatory and Antioxidative Activities of Safranal in the Reduction of Renal Dysfunction and Damage that Occur in Diabetic Nephropathy.

Authors:  Ömer Hazman; Mehmet Fatih Bozkurt
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

2.  Influence of culinary processing time on saffron's bioactive compounds (Crocus sativus L.).

Authors:  Lidia Rodríguez-Neira; María Asunción Lage-Yusty; Julia López-Hernández
Journal:  Plant Foods Hum Nutr       Date:  2014-12       Impact factor: 3.921

3.  Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice.

Authors:  Yazan S Batarseh; Sonali S Bharate; Vikas Kumar; Ajay Kumar; Ram A Vishwakarma; Sandip B Bharate; Amal Kaddoumi
Journal:  ACS Chem Neurosci       Date:  2017-05-15       Impact factor: 4.418

Review 4.  Evaluation of antioxidant activities of bioactive compounds and various extracts obtained from saffron (Crocus sativus L.): a review.

Authors:  Somayeh Rahaiee; Sohrab Moini; Maryam Hashemi; Seyed Abbas Shojaosadati
Journal:  J Food Sci Technol       Date:  2014-03-11       Impact factor: 2.701

Review 5.  Natural compounds for pediatric cancer treatment.

Authors:  Veronica Ferrucci; Iolanda Boffa; Gina De Masi; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-09       Impact factor: 3.000

6.  The effect of salt stress on the production of apocarotenoids and the expression of genes related to their biosynthesis in saffron.

Authors:  Fateme Sadat Moslemi; Atousa Vaziri; Golandam Sharifi; Javad Gharechahi
Journal:  Mol Biol Rep       Date:  2021-02-21       Impact factor: 2.316

7.  Use of in vitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell line.

Authors:  Saeed Samarghandian; Mohammad Hossein Boskabady; Saideh Davoodi
Journal:  Pharmacogn Mag       Date:  2010-10       Impact factor: 1.085

Review 8.  Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis.

Authors:  Bharat B Aggarwal; Michelle E Van Kuiken; Laxmi H Iyer; Kuzhuvelil B Harikumar; Bokyung Sung
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

9.  Saffron reduces ATP-induced retinal cytotoxicity by targeting P2X7 receptors.

Authors:  Lucia Corso; Anna Cavallero; Debora Baroni; Patrizia Garbati; Gianfranco Prestipino; Silvia Bisti; Mario Nobile; Cristiana Picco
Journal:  Purinergic Signal       Date:  2016-01-07       Impact factor: 3.765

10.  Crocus sativus L. (Saffron) extract and its active constituents (crocin and safranal) on ischemia-reperfusion in rat skeletal muscle.

Authors:  Hossein Hosseinzadeh; Mohammad Hadi Modaghegh; Zahra Saffari
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.